tiprankstipranks
Advertisement
Advertisement

SRPT Stock Latest News

H.C. Wainwright says Sarepta news does not signal full approvals
The FlyH.C. Wainwright says Sarepta news does not signal full approvals
12h ago
SRPT
Sarepta announces FDA acceptance of sNDAs for AMONDYS 45, VYONDYS 53
PremiumThe Fly
Sarepta announces FDA acceptance of sNDAs for AMONDYS 45, VYONDYS 53
1d ago
SRPT
Sarepta Shareholders Approve 2026 Equity and ESPP Plans
PremiumCompany Announcements
Sarepta Shareholders Approve 2026 Equity and ESPP Plans
27d ago
8K
SRPT
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
27d ago
AZN
BMY
SRPT Expands Into Huntington’s Disease With New First-in-Human Trial
PremiumCompany Announcements
SRPT Expands Into Huntington’s Disease With New First-in-Human Trial
27d ago
SRPT
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe FlyFDA issues draft guidance to help accelerated cell, gene therapies for patients
29d ago
AZN
BMY
Sarepta Therapeutics: Buy Rating Reiterated on Elevidys Uptake Outlook and Microdystrophin Validation; $35 Price Target Unchanged
Premium
Ratings
Sarepta Therapeutics: Buy Rating Reiterated on Elevidys Uptake Outlook and Microdystrophin Validation; $35 Price Target Unchanged
2M ago
SRPT
Sarepta price target lowered to $19 from $20 at Evercore ISI
Premium
The Fly
Sarepta price target lowered to $19 from $20 at Evercore ISI
2M ago
SRPT
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
2M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
2M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
2M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
2M ago
DYN
RNA
Sarepta Therapeutics: Pipeline Binary Risks and Elevidys Uptake Uncertainty Support Neutral Rating Through 2026
PremiumRatingsSarepta Therapeutics: Pipeline Binary Risks and Elevidys Uptake Uncertainty Support Neutral Rating Through 2026
2M ago
SRPT
Sarepta Therapeutics: Hold Rating Reaffirmed as Strong Elevidys Sales Offset by Pipeline and Execution Uncertainties
Premium
Ratings
Sarepta Therapeutics: Hold Rating Reaffirmed as Strong Elevidys Sales Offset by Pipeline and Execution Uncertainties
2M ago
SRPT
Gil Blum Reiterates Sell on Sarepta as Elevidys Momentum Slows and Regulatory Risks Mount
Premium
Ratings
Gil Blum Reiterates Sell on Sarepta as Elevidys Momentum Slows and Regulatory Risks Mount
2M ago
SRPT
Sarepta Therapeutics: Safety Overhangs and Regulatory Uncertainty Reinforce Sell Rating and Unchanged $13 Price Target
PremiumRatings
Sarepta Therapeutics: Safety Overhangs and Regulatory Uncertainty Reinforce Sell Rating and Unchanged $13 Price Target
2M ago
SRPT
Ritu Baral Reiterates Hold on Sarepta, Maintains $17 Price Target Amid Mixed Operating Profile and Balanced Risk-Reward
PremiumRatings
Ritu Baral Reiterates Hold on Sarepta, Maintains $17 Price Target Amid Mixed Operating Profile and Balanced Risk-Reward
2M ago
SRPT
Sarepta reports Q1 adjusted EPS $3.16 vs ($3.42) last year
PremiumThe Fly
Sarepta reports Q1 adjusted EPS $3.16 vs ($3.42) last year
2M ago
SRPT
Sarepta Therapeutics Signals Profits Amid Alevitus Tests
PremiumCompany Announcements
Sarepta Therapeutics Signals Profits Amid Alevitus Tests
2M ago
SRPT
SRPT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSRPT Upcoming Earnings Report: What to Expect?
2M ago
SRPT
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
Premium
The Fly
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
2M ago
BA
BE
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
Premium
The Fly
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
3M ago
CHRO
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >